94P Patient-reported outcomes (PROs) following sintilimab (sint) plus pemetrexed (pem) and platinum (plt) based chemotherapy as first-line therapy for locally advanced or metastatic nonsquamous NSCLC: A randomized, double-blind, phase III study (Orient-11)
Saved in:
| Title: | 94P Patient-reported outcomes (PROs) following sintilimab (sint) plus pemetrexed (pem) and platinum (plt) based chemotherapy as first-line therapy for locally advanced or metastatic nonsquamous NSCLC: A randomized, double-blind, phase III study (Orient-11) |
|---|---|
| Authors: | Fang, J.1 (AUTHOR), Zhao, Y.2,3 (AUTHOR), Han, B.4 (AUTHOR), Chen, G.5 (AUTHOR), Yang, Z.6 (AUTHOR), Bi, M.7 (AUTHOR), Zhang, L.2,8 (AUTHOR), Molife, C.9 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 7, Vol. 32, pS1415-S1415. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 153829397 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 94P Patient-reported outcomes (PROs) following sintilimab (sint) plus pemetrexed (pem) and platinum (plt) based chemotherapy as first-line therapy for locally advanced or metastatic nonsquamous NSCLC: A randomized, double-blind, phase III study (Orient-11) – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Fang%2C+J%2E%22">Fang, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Y%2E%22">Zhao, Y.</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Han%2C+B%2E%22">Han, B.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+G%2E%22">Chen, G.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Z%2E%22">Yang, Z.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bi%2C+M%2E%22">Bi, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+L%2E%22">Zhang, L.</searchLink><relatesTo>2,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Molife%2C+C%2E%22">Molife, C.</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2021 Supplement 7, Vol. 32, pS1415-S1415. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=153829397 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2021.10.112 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1415 Titles: – TitleFull: 94P Patient-reported outcomes (PROs) following sintilimab (sint) plus pemetrexed (pem) and platinum (plt) based chemotherapy as first-line therapy for locally advanced or metastatic nonsquamous NSCLC: A randomized, double-blind, phase III study (Orient-11) Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fang, J. – PersonEntity: Name: NameFull: Zhao, Y. – PersonEntity: Name: NameFull: Han, B. – PersonEntity: Name: NameFull: Chen, G. – PersonEntity: Name: NameFull: Yang, Z. – PersonEntity: Name: NameFull: Bi, M. – PersonEntity: Name: NameFull: Zhang, L. – PersonEntity: Name: NameFull: Molife, C. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 12 Text: 2021 Supplement 7 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 32 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
